AAPP Scientific Poster Session Abstracts
Currently Viewing Abstracts from 2004
2004
| 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026
| Title | Presenter | Type | Session |
|---|---|---|---|
: RELATIVE RATES OF COMPLETE SYMPTOM RELIEF IN DEPRESSED PATIENTS TREATED WITH VENLAFAXINE OR SSRIS
|
Encore Presentation | ||
|
A DECISION ANALYTIC MODEL OF THE ECONOMIC BENEFITS OF REMISSION: COMPARISON OF VENLAFAXINE AND SSRIS
|
Original Research | ||
|
A NATURALISTIC TRIAL WITH ARIPIPRAZOLE IN A GENERAL PSYCHIATRIC SETTING
|
Encore Presentation | ||
|
A WELLNESS INTERVENTION PROGRAM FOR PATIENTS WITH SERIOUS AND PERSISTENT MENTAL ILLNESS
|
Best Practices | ||
|
Antiandrogens as a Treatment of Aggression: A Case Series
|
Work in Progress | ||
|
Antidepressant Induced Apathy
|
Work in Progress | ||
|
ARIPIPRAZOLE vs PERPHENAZINE IN TREATMENT-RESISTANT SCHIZOPHRENIA
|
Encore Presentation | ||
|
ARIPIPRAZOLE vs PLACEBO IN ACUTE MANIA: RESULTS FROM A SECOND STUDY
|
Encore Presentation | ||
|
ARIPIPRAZOLE vs PLACEBO IN ACUTE MANIA: SAFETY AND TOLERABILITY POOLED ANALYSIS
|
Encore Presentation | ||
|
ATOMOXETINE AND METHYLPHENIDATE EFFECTS ON SLEEP IN CHILDREN WITH ADHD
|
Original Research | ||
|
ATOMOXETINE EFFICACY FOR SEVERE HYPERACTIVE AND INATTENTIVE ADHD SYMPTOMS
|
Original Research | ||
|
Atypical Antipsychotic Medication Compliance in a Schizophrenia Population
|
Original Research | ||
|
Beneficial Psychiatric Effects Secondary to Levetiracetam Therapy in the Developmentally Delayed Population: A Case Series Report
|
Original Research | ||
|
BIOAVAILABILITY OF AN ORAL SOLUTION OF THE ANTIPSYCHOTIC ARIPIPRAZOLE
|
Original Research | ||
|
Clinical Outcomes of a Self-Medication Education and Behavioral Training Program for Severely Mentally Ill Veterans
|
Work in Progress | ||
|
COMPARISON OF MEDICATION ADHERENCE RATES AMONG PATIENTS RECEIVING ANTIPSYCHOTIC AGENTS
|
Original Research | ||
|
COMPARISON OF OLANZAPINE AND LITHIUM TREATMENT GROUPS BASED ON LITHIUM BLOOD LEVELS: A 52-WEEK BIPOLAR RELAPSE PREVENTION STUDY
|
Original Research | ||
|
COMPLETE RESOLUTION OF SOMATIC SYMPTOMS OF DEPRESSION WITH VENLAFAXINE OR SSRIS
|
Encore Presentation | ||
|
Cost Savings in Switching From Wellbutrin SR (R) to Generic Bupropion at Alaska Native Medical Center
|
Original Research | ||
|
DEFINITIVE EVIDENCE THAT ARIPIPRAZOLE IS A D2 AND 5-HT1A PARTIAL AGONIST
|
Encore Presentation | ||
|
Development of a Customized Database to Document Psychiatric Clinical Pharmacist Recommendations
|
Best Practices | ||
|
Differences Among Antipsychotics in the Time to All-Cause Drug Discontinuation: Results from a Longitudinal Naturalistic Study of Schizophrenia.
|
Original Research | ||
|
Direct and indirect cost savings associated with adding Risperdal® M-Tab™ to a university medical center formulary
|
Original Research | ||
|
DULOXETINE IN THE TREATMENT OF THE PAIN ASSOCIATED WITH DIABETIC NEUROPATHY
|
Encore Presentation | ||
|
DULOXETINE VS PLACEBO IN THE PREVENTION OF RELAPSE OF MAJOR DEPRESSIVE DISORDER
|
Encore Presentation | ||
|
EFFECT OF ATOMOXETINE IN TREATING PEDIATRIC ADHD IN A NATURAL SETTING
|
Original Research | ||
|
Effect of bupropion on cytochrome P450 2D6 (CYP2D6) activity
|
Original Research | ||
|
EFFECT OF OLANZAPINE/FLUOXETINE ON CORE MOOD SYMPTOMS IN BIPOLAR DEPRESSION
|
Original Research | ||
|
EFFECTS OF RENAL AND HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS OF ARIPIPRAZOLE
|
Encore Presentation | ||
|
EFFECTS OF TIME OF DOSING AND FOOD ON ARIPIPRAZOLE PHARMACOKINETICS
|
Encore Presentation | ||
|
Electrocardiographic Evaluation of Ziprasidone Intramuscular Formulation in Children
|
Work in Progress | ||
|
EMOTIONAL AND PAINFUL PHYSICAL SYMPTOMS ASSOCIATED WITH DEPRESSION RESPOND TO DULOXETINE, A DUAL ACTION SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITOR
|
Original Research | ||
|
Evaluation of a Pharmacy Intervention in Geriatric Assisted Living Facility Residents
|
Work in Progress | ||
|
Evaluation of Medication Adherence and Healthcare Utilization in the Psychiatric Population
|
Original Research | ||
|
EVALUATION OF THE DRUG INTERACTION POTENTIAL OF CITALOPRAM (C) COMPARED TO PAROXETINE (P) AND FLUOXETINE (F) ON CYP2D6 USING DEXTROMETHORPHAN (DM) PROBE METHODOLOGY
|
Original Research | ||
|
Extended-Release Divalproex for Mood Stabilization
|
Encore Presentation | ||
|
FASTING GLUCOSE AND LIPIDS IN SCHIZOPHRENIC PATIENTS TREATED WITH OLANZAPINE OR ZIPRASIDONE
|
Encore Presentation | ||
|
GUANFACINE AUGMENTATION FOR THE REMEDIATION OF ATTENTION
|
Work in Progress | ||
|
IMPROVEMENT IN DEPRESSION-RELATED FATIGUE AMONG PATIENTS TREATED WITH VENLAFAXINE, SSRIS, OR PLACEBO
|
Original Research | ||
|
IMPROVEMENT OF COMORBID DEPRESSION WITH OLANZAPINE VERSUS ZIPRASIDONE TREATMENT IN PATIENTS WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER
|
Encore Presentation | ||
|
INTRAMUSCULAR ARIPIPRAZOLE IN ACUTELY AGITATED PSYCHOTIC PATIENTS
|
Original Research | ||
|
Is It Safe for My Baby?: The re-development of a popular resource about the risks and recommendations for the use of medication, alcohol, tobacco and other drugs during pregnancy and breastfeeding.
|
Best Practices | ||
|
LAMOTRIGINE THERAPY IN PATIENTS WITH MENTAL RETARDATION AND REFRACTORY EPILEPSY IN INSTITUTIONAL AND HOME SETTINGS
|
Encore Presentation | ||
|
LONG-TERM EFFICACY OF ARIPIPRAZOLE IN THE MAINTENANCE TREATMENT OF BIPOLAR DISORDER
|
Encore Presentation | ||
|
MEMANTINE IS SAFE FOR SHORT- AND LONG-TERM TREATMENT OF DEMENTIA
|
Encore Presentation | ||
|
MEMANTINE MONOTHERAPY IS EFFECTIVE AND SAFE FOR THE TREATMENT OF MILD TO MODERATE ALZHEIMER\'S DISEASE: A RANDOMIZED CONTROLLED TRIAL
|
Encore Presentation | ||
|
Monitoring of Adherence to Ziprasidone Contraindications
|
Original Research | ||
|
OLANZAPINE COMPARED TO OTHER ATYPICALS: RELAPSE PREVENTION IN SCHIZOPHRENIA
|
Encore Presentation | ||
|
Open Label Withdrawal of Antipsychotic Drugs from Patients with Schizophrenia Treated Concomitantly with Atypicals Antipsychotics Drugs
|
Work in Progress | ||
|
Oral SAMe and Lack of Toxicity
|
Original Research | ||
|
PATIENTS TREATED WITH QUETIAPINE DEVELOP TOLERANCE TO SOMNOLENCE: PRECLINICAL MECHANISM AND CLINICAL EVIDENCE
|
Original Research | ||
|
Pharmacoeconomic Considerations of Polypharmacy with Psychotropic Medications
|
Work in Progress | ||
|
Pharmacy students on psychiatry rotations - a unique instructional activity
|
Best Practices | ||
|
PRELIMINARY PHARMACOKINETICS AND TOLERABILITY OF HIGHER DOSE OLANZAPINE
|
Encore Presentation | ||
|
Prevalence and motivations for the illicit use of prescription stimulants in an undergraduate student sample.
|
Original Research | ||
|
Psychiatric Effects Associated with Efavirenz: A Retrospective Study
|
Encore Presentation | ||
|
PSYCHOTROPIC-INDUCED WEIGHT GAIN AND QUALITY OF LIFE ASSESSMENT IN PSYCHIATRIC PATIENTS OF A VETERAN’S AFFAIRS HOSPITAL IN SOUTH AUSTRALIA
|
Work in Progress | ||
|
Risk of Rehospitalization: Olanzapine versus Quetiapine
|
Original Research | ||
|
SAFETY AND TOLERABILITY PROFILE OF ARIPIPRAZOLE IN ELDERLY PATIENTS WITH PSYCHOSIS OF ALZHEIMER’S DISEASE: A POOLED ANALYSIS
|
Original Research | ||
|
SAFETY OF INTRAMUSCULAR OLANZAPINE IN COMORBIDLY ILL, ACUTELY AGITATED PATIENTS WITH DEMENTIA
|
Original Research | ||
|
SHORT-TERM TREATMENT OF PTSD WITH VENLAFAXINE XR, SERTRALINE, AND PLACEBO
|
Encore Presentation | ||
|
Stability Of Clozapine In Oral Suspension
|
Encore Presentation | ||
|
The association of metabotropic glutamate receptor 3 (GRM3) gene polymorphisms with clinical response to olanzapine
|
Work in Progress | ||
|
The Cost of Severe Agiation at a State psychiatric Hospital
|
Original Research | ||
|
THE EFFECTS OF SWITCHING ANTIPSYCHOTICS ON LIPIDS: A RETROSPECTIVE CHART REVIEW
|
Encore Presentation | ||
|
THE EFFICACY AND SAFETY OF QUETIAPINE VERSUS DIVALPROEX SODIUM IN THE TREATMENT OF BIPOLAR MANIA
|
Encore Presentation | ||
|
THE IMPACT OF TOPIRAMATE ON SERUM BICARBONATE CONCENTRATIONS IN ADULT PATIENTS RECEIVING ANTIEPILEPTIC THERAPY
|
Original Research | ||
|
THE INFLUENCE OF STUDY DESIGN ON THE RESULTS OF PHARMACOEPIDEMIOLOGIC STUDIES OF DIABETES RISK WITH ANTIPSYCHOTIC THERAPY
|
Original Research | ||
|
The long-term impact of group attendance, function and psychotropic medications on weight loss in a pharmacy-based weight management clinic in psychiatry.
|
Best Practices | ||
|
The Rate of Adherence with Atypical Antipsychotics Among Schizophrenic Patients
|
Work in Progress | ||
|
TREATMENT OF CHRONIC PAIN WITH VENLAFAXINE XR
|
Encore Presentation | ||
|
Treatment Patterns and Medication Costs of Bipolar Disorder Compared to Schizophrenia and Unipolar Depression
|
Original Research | ||
|
UTILIZATION ANALYSIS OF HEALTHCARE RESOURCES FOR PATIENTS TREATED WITH ATYPICAL ANTIPSYCHOTICS
|
Original Research | ||
|
VENLAFAXINE XR IN THE TREATMENT OF PANIC DISORDER
|
Encore Presentation |